Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-03

FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for tiagabine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating a labeling-related regulatory action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiagabine hydrochloride (tiagabine hydrochloride)

Snippet

SUPPL AP for TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)